Evidence map›Paper›PMID 36808266›Full record

ArticleBiochemical genetics2023

Circ_0001715 Functions as a miR-1249-3p Sponge to Accelerate the Progression of Non-small Cell Lung Cancer via Upregulating the Level of FGF5.

Quanjin Zhang, Feng Ding, Congcong Zhang, Xu Han, Hui Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Quanjin ZhangPediatric Cardiothoracic Surgery, Huaibei People's Hospital, 66 Huaihai Xi Lu, Huaibei, 235000, Anhui, China.
Feng DingPediatric Cardiothoracic Surgery, Huaibei People's Hospital, 66 Huaihai Xi Lu, Huaibei, 235000, Anhui, China.
Congcong ZhangPediatric Cardiothoracic Surgery, Huaibei People's Hospital, 66 Huaihai Xi Lu, Huaibei, 235000, Anhui, China.
Xu HanPediatric Cardiothoracic Surgery, Huaibei People's Hospital, 66 Huaihai Xi Lu, Huaibei, 235000, Anhui, China.
Hui ChengPediatric Cardiothoracic Surgery, Huaibei People's Hospital, 66 Huaihai Xi Lu, Huaibei, 235000, Anhui, China. zx17730227060@163.com.
Huaibei Normal University · CNHuaibei Mining (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) have been widely involved in the malignant development of human cancers. Circ_0001715 was aberrantly upregulated in non-small cell lung cancer (NSCLC). However, circ_0001715 function has never been researched. This study was designed to investigate the role and mechanism of circ_0001715 in NSCLC. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to examine the levels of circ_0001715, microRNA-1249-3p (miR-1249-3p) and Fibroblast Growth Factor 5 (FGF5). The proliferation detection was conducted using colony formation assay and EdU assay. Cell apoptosis was analyzed via flow cytometry. Wound healing assay and transwell assay were used for determination of migration and invasion, respectively. The protein levels were measured through western blot. Target analysis was carried out via dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Xenograft tumor model was established in mice for in vivo research. The significant upregulation of circ_0001715 was detected in NSCLC samples and cells. Circ_0001715 knockdown induced the inhibitory effects on proliferation, migration and invasion but the promoting effect on apoptosis of NSCLC cells. Circ_0001715 could interact with miR-1249-3p. The regulatory role of circ_0001715 was achieved by sponging miR-1249-3p. Furthermore, miR-1249-3p targeted FGF5 and miR-1249-3p acted as a cancer inhibitor by targeting FGF5. Moreover, circ_0001715 upregulated the FGF5 level via targeting miR-1249-3p. In vivo assay showed that circ_0001715 promoted the NSCLC progression through the miR-1249-3p/FGF5 axis. The current evidence elucidated that circ_0001715 served as an oncogenic regulator in NSCLC progression by depending on the miR-1249-3p/FGF5 axis.

Indexed as

Carcinoma, Non-Small-Cell LungFibroblast Growth Factor 5Lung NeoplasmsMicroRNAsRNA, CircularAnimalsApoptosisCell Line, TumorCell ProliferationDisease Models, AnimalHumansMiceFGF5 protein, humanFibroblast Growth Factor 5MicroRNAsMIRN1249 microRNA, humanRNA, CircularCirc_0001715FGF5miR-1249-3pNon-small cell lung cancer

Identifiers

PMID36808266
OpenAlexW4321436226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.